Sector revisions Gilead Sciences, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
138.36 ^USD	+0.16%		+3.87%	+12.73%

08-11	Global drugmakers invest billions to boost US presence	RE
08-11	Nucleai And Gilead Sciences Advance AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GILEAD SCIENCES, INC.							27
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							22
	ABBVIE INC.							29
	ROCHE HOLDING AG							18
	NOVARTIS AG							21
	ASTRAZENECA PLC							22
	AMGEN INC.							29
	NOVO NORDISK A/S							24
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							24
	VERTEX PHARMACEUTICALS INCORPORATED							25
	SANOFI							23
	GSK PLC							20
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							16
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							10
	HALEON PLC							17
	Average							22
	Weighted average by Cap.							24